|
⚲
|
| Keyboard |
| Pappas Capital LLC | |
|---|---|
| Firm | Pappas Capital LLC |
| Address | 2520 Meridian Pkwy, Suite 400 Durham, NC 27713 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Pappas Capital LLC | |||||
| PV VI CEO Fund LP | 021-437189 | Promoter | of 25.0 M |
5.9 M | |
| Asia Innovation Ventures LP | 021-413785 | Promoter | 200.0 M of 200.0 M |
84.0 M | |
| AM Pappas Life Science Ventures V LP | 021-281210 | Promoter | 85.8 M of 85.8 M |
9.6 M | |
| PV V CEO Fund LP | 021-281212 | Promoter | 7.0 M of 7.0 M |
0.9 M | |
| Levert Ventures LP | 021-506310 | Director | of 50.0 M |
||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Liquidia Technologies Inc LQDA
Common Stock, par value $0.001 per share
|
2018-07-30 | Conversion | 97,287 | ||
|
Liquidia Technologies Inc LQDA
Series C Preferred Stock, par value $0.001 per share · derivative
|
2018-07-30 | Conversion | 1,481,553 | $0.00 | |
|
Liquidia Technologies Inc LQDA
Common Stock, par value $0.001 per share
|
2018-07-30 | Conversion | 191,788 | ||
|
Liquidia Technologies Inc LQDA
Series D Preferred Stock, par value $0.001 per share · derivative
|
2018-07-30 | Conversion | 1,637,091 | $0.00 | |
|
Kezar Life Sciences Inc KZR
Series B Preferred Stock, par value $0.001 per share · derivative
|
2018-06-25 | Conversion | 290,924 | $0.00 | |
|
Kezar Life Sciences Inc KZR
Series B Preferred Stock, par value $0.001 per share · derivative
|
2018-06-25 | Conversion | 23,894 | $0.00 | |
|
Kezar Life Sciences Inc KZR
Common Stock, par value $0.001 per share
|
2018-06-25 | Conversion | 23,894 | ||
|
Kezar Life Sciences Inc KZR
Common Stock, par value $0.001 per share
|
2018-06-25 | Conversion | 290,924 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2017-03-01 | Tender | 1,871,049 | $46.50 | 87,003,778 |
|
CoLucid Pharmaceuticals Inc CLCD
Stock Option (Right to Buy) · derivative
|
2017-03-01 | Disposed to issuer | 5,954 | $36.50 | 217,321 |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2017-03-01 | Tender | 116,317 | $46.50 | 5,408,740 |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2017-03-01 | Tender | 5,528 | $46.50 | 257,052 |
|
CoLucid Pharmaceuticals Inc CLCD
Stock Option (Right to Buy) · derivative
|
2017-03-01 | Disposed to issuer | 8,897 | $40.26 | 358,193 |
|
CoLucid Pharmaceuticals Inc CLCD
Series C Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 20,808 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Buy | 282,440 | $10.00 | 2,824,400 |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Conversion | 98,757 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Buy | 17,560 | $10.00 | 175,600 |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Conversion | 1,588,607 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Series B Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 41,996 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Series B Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 675,588 | $0.00 | |
| showing 20 of 32 most recent transactions | |||||